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INTRODUCTION
The QT interval is the duration 
between depolarization and 
repolarization of the ventricular 
myocardium. Because the QT 
interval is highly influenced by 
the heart rate, a corrected QT 
(QTc) interval adjusted for the 
heart rate has been proposed 
from an electrophysiology 
perspective [1]. Prolonged QTc 
interval is well-known to be an 
arrhythmogenic parameter in 
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ABSTRACT
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is clinically important because of its association 
with an increased risk of sudden cardiac death as well as liver-related mortality. Most cases of sudden cardiac 
death could be mediated by an arrhythmogenic process. Thus, we aimed to determine the association between 
NAFLD and corrected QT (QTc) interval in apparently healthy Korean women.
Methods: This cross-sectional study included 764 women aged 20 to 74 years old who underwent a health 
examination program between 2014 and 2015. The QTc interval was calculated using Bazett’s formula (QTc = 
QT/√RR). Multiple linear and logistic regression analysis were performed to assess independent relationships 
between NAFLD and QTc interval and prolonged QTc (≥ 450 milliseconds) was calculated after adjusting 
for confounding variables.
Results: The overall prevalence of NAFLD was 23.5% in general healthy women. The standardized β coefficient 
(95% confidence interval) of the QTc increment in patients with NAFLD was 6.4 milliseconds (1.2–11.8) 
through multiple linear regression analysis after adjusting for age, body mass index, smoking status, and 
regular exercise as well as mean arterial pressure, fasting plasma glucose, triglycerides, high-density lipoprotein 
cholesterol, aspartate aminotransferase, alanine aminotransferase, calcium, potassium levels and menopause 
status. Similarly, the odds ratio (95% confidence interval) of NAFLD for prolonged QTc was 2.05 (1.13–3.71) 
according to multiple logistic regression analysis after adjusting for the same covariables in women aged 20 
to 74 years old.
Conclusion: We demonstrated the arrhythmogenic potential of NAFLD, implying that careful monitoring 
of patient electrocardiograms is necessary to evaluate the possible arrhythmic risk in general healthy women 
with NAFLD.
 
Key words: nonalcoholic fatty liver disease – insulin resistance – QTc interval – arrhythmia
Abbreviations: BMI: body mass index; CI: confidence interval; DBP: diastolic blood pressure; ECG: 
electrocardiography; HDL: high-density lipoprotein; IQRs: interquartile ranges; ms: milliseconds; NAFLD: 
nonalcoholic fatty liver disease; NCEP-ATP III: National Cholesterol Education Program Adult Treatment 
Panel III; QTc: corrected QT; SBP: systolic blood pressure. 
electrocardiography (ECG) and is associated with electrical 
instability of the myocardium including ventricular tachycardia 
and fibrillation, which leads to sudden cardiac death [2, 
3]. Prolonged QTc interval is a useful predictor for sudden 
cardiac death in patients after acute coronary syndrome and 
with heart failure and type 2 diabetes and even in apparently 
healthy adults [4]. 
Nonalcoholic fatty liver disease (NAFLD) is characterized 
by diffuse triglycerides accumulation in the liver not caused 
by excessive alcohol use and other causes of liver disease. With 
the growing epidemic of obesity, NAFLD is one of the most 
prevalent causes of chronic liver disease and encompasses 
a spectrum of clinical syndromes ranging from simple 
steatosis to nonalcoholic steatohepatitis that could progress 
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to advanced fibrosis, cirrhosis, and cirrhosis complicated by 
hepatocellular carcinoma [5]. More recently, accumulating 
evidence suggests that NAFLD is associated with an increased 
risk of cardiovascular disease, chronic kidney disease, and 
sudden cardiac death as well as liver related mortality [6, 
7]. Because most cases of sudden cardiac death are related 
to severe ventricular arrhythmia, we expected that the link 
between NAFLD and sudden cardiac death may be mediated 
by an arrhythmogenic process. Although, several previous 
studies reported prolonged QTc intervals in subjects with 
NAFLD, most studies have been limited to Western populations 
with chronic medical conditions such as type 2 diabetes and 
admitted patients. Therefore, in the present study, we examined 
the association between NAFLD and QTc interval in apparently 
healthy Korean women. 
METHODS
Study participants
We retrospectively reviewed the medical records of 898 
participants aged 20 years or older who underwent a medical 
examination at the Health Promotion Center, Seoul between 
2014 and 2015. The subjects voluntarily visited the health 
promotion center to regularly undergo health assessment. 
Informed consent was obtained from each participant. This 
study was conducted in accordance with the ethical principles 
of the Declaration of Helsinki and was approved by the 
Institutional Review Board of Yonsei University College of 
Medicine, Seoul. We excluded participants who met one or 
more of the following criteria (n = 134): missing data; alcohol 
intake of 70 g/week or more, a positive test for hepatitis 
B antigens or hepatitis C antibodies; a history of cardiac 
arrhythmia, ischemic heart disease, stroke, cancer, thyroid, 
respiratory, renal, hepatobiliary, or rheumatologic disease; and 
failure to fast for 12h prior to testing. A total of 764 women 
aged 20 to 74 years old were included in the final analysis. A 
flow diagram of the study participants is showed in Fig. 1.
Data collection
Each participant completed a questionnaire about 
lifestyle and medical history. Self-reported cigarette smoking, 
alcohol consumption, and physical activity characteristics 
were gleaned from the questionnaires. The smoking statuses 
were nonsmoker, ex-smoker, and current smoker. Questions 
regarding alcohol intake included the frequency on a weekly 
basis. Regular alcohol consumption was defined as alcohol 
drinking two or more times per week. Participants were asked 
about their physical exercise on a weekly basis, and regular 
exercise was defined as exercise three times or more per week. 
Body mass and height were measured to the nearest 0.1 kg 
and 0.1 cm, respectively, with the participant in light indoor 
clothing without shoes. Body mass index (BMI) was calculated 
as the weight in kilograms divided by the square of the height 
in meters (kg/m2). Systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were measured using the patient’s 
right arm with a standard mercury sphygmomanometer 
(Baumanometer; W.A. Baum Co. Inc., Copiague, NY, USA). 
Mean arterial pressure was calculated using the equation 
(SBP + 2×DBP)/3. All blood samples were obtained from 
the antecubital vein after a 12-h overnight fast. Fasting 
plasma glucose, total cholesterol, triglycerides, and high-
density lipoprotein (HDL) cholesterol levels were measured 
by enzymatic methods using a chemistry analyzer (Hitachi 
7600-110; Hitachi, Ltd., Tokyo, Japan). The modified National 
Cholesterol Education Program Adult Treatment Panel III 
(NCEP-ATP III) was used to define metabolic syndrome. 
Because waist circumference was not measured, we defined 
obesity as a BMI 25 kg/m2 or more, as suggested by the position 
statement of the American College of Endocrinology [8]. 
Therefore, metabolic syndrome was defined by the presence of 
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Fig. 1. Flow diagram of the study participants.
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three or more of the following risk factors: obesity, with BMI 
25.0 kg/m2 or more; elevated systolic blood pressure (SBP) of 
130 mmHg or more, elevated diastolic blood pressure (DBP) of 
85 mmHg or more, or use of an antihypertensive medication; 
high fasting plasma glucose of 100 mg/dL or more or the use of 
an antidiabetic medication; high triglyceride level of 150 mg/
dL or more; and low HDL cholesterol level of less than 40 mg/
dL for men and less than 50 mg/dL for women, respectively. 
Each participant underwent resting standard supine 12-
lead ECG at a paper speed of 25 mm/s and amplitude of 10 mm/
mv using a Marquette MAC 12 (Marquette Medical Systems, 
Inc., Milwaukee, WI, USA). The QT and R–R intervals were 
measured over three consecutive cycles on leads V2 or V3. 
The QT intervals were measured from the beginning of the 
QRS complex of the ECG to the end of the T-wave and were 
corrected according to Bazett’s formula (QTc = QT/√RR) [1].
Diagnosis of nonalcoholic fatty liver disease
A diagnosis of fatty liver was based on abdominal 
ultrasonography with a 3.5-MHz transducer (HDI 5000; 
Philips, Bothell, WA, USA). Ultrasonography was performed 
by two experienced radiologists who were unaware of the aims 
of the study and blinded to laboratory findings. We analyzed the 
linear weighted kappa statistics to analyze agreement between 
the two radiologists because the outcome encompasses ordinal 
scoring, and the kappa index (95% CI) was 0.809 (0.782–0.867). 
The presence of hepatic steatosis was determined according 
to the findings of high hepatorenal echo contrast, bright 
liver, or attenuation of ultrasound in a deep area of the liver. 
Hepatic steatosis was graded according to criteria previously 
described: mild, slight diffuse increase in bright homogeneous 
echoes in liver parenchyma, with normal visualization of the 
diaphragm and portal and hepatic vein borders, and normal 
hepatorenal contrast; moderate, diffuse increase in bright 
echoes in liver parenchyma, with slightly impaired visualization 
of the peripheral portal and hepatic vein borders; and severe, 
marked increase in bright echoes at a shallow depth, with deep 
attenuation and impaired visualization of the diaphragm and 
marked vascular blurring [9]. Liver with any degree of hepatic 
steatosis was considered as having NAFLD in this study.
Statistical analysis
Normal distribution was evaluated with determination 
of skewness using a Kolmogorov–Smirnov test. Serum 
triglycerides, aspartate aminotransferase, and alanine 
aminotransferase levels have skewed distributions, so these 
variables were expressed as medians (interquartile ranges; 
IQRs) in descriptive analysis and log-transformed prior to 
simple correlation and multiple regression analysis. The 
clinical characteristics of the study population according to 
the presence of NAFLD were compared using an independent 
two-sample Student’s t-test for continuous variables and the 
chi-squared test for categorical variables. Continuous data are 
presented as means (standard deviations; SDs) or medians 
(IQRs), and categorical data are presented as frequencies. The 
Pearson’s correlation coefficients were determined for QTc 
versus age, BMI, blood pressure, fasting plasma glucose, total 
cholesterol, log-transformed triglycerides, HDL cholesterol, 
aminotransferase, calcium, and potassium levels. Prolonged 
QTc interval was defined as one of 450 milliseconds (ms) or 
more in women according to a previous Korean epidemiologic 
study [10]. Multiple linear regression analysis was performed 
to assess independent relationships between NAFLD and 
QTc interval. Also, the odds ratios (ORs) and 95% confidence 
intervals (95% CIs) for prolonged QTc (≥ 450 ms) were 
calculated after adjusting for confounding variables using 
multiple logistic regression analysis. All analyses were 
conducted using the SAS statistical software (version 9.4; SAS 
Institute Inc., Cary, NC, USA). All statistical tests were two-
sided, and statistical significance was determined at p < 0.05.
RESULTS
Table I shows the clinical characteristics of the study 
population according to the presence of NAFLD (23.4%). The 
mean values of BMI, blood pressures, fasting plasma glucose, 
total cholesterol, and triglyceride levels and the median 
values of triglycerides and aminotransferases were higher in 
individuals with NAFLD than in individuals without. The 
prevalence rates of hypertension, type 2 diabetes, and metabolic 
Table I. Clinical characteristics of the study population according to the 
presence of nonalcoholic fatty liver disease (NAFLD).
NAFLD (-) NAFLD (+) p
No. or patients 585 179
Age (years) 45.7 (8.2) 50.1 (7.6) <0.001
Body mass index (kg/m2) 22.9 (2.5) 26.0 (2.9) <0.001
Systolic blood pressure (mmHg) 118.2 (16.0) 128.1 (14.4) <0.001
Diastolic blood pressure 
(mmHg)
73.1 (9.6) 79.7 (9.0) <0.001
Mean arterial pressure (mmHg) 88.1 (11.4) 95.8 (10.4) <0.001
Fasting plasma glucose (mg/dL) 87.2(113.7) 95.5 (16.5) <0.001
Triglycerides (mg/dL) 99 (72-137) 152 (110-214) <0.001
HDL-cholesterol (mg/dL) 59.3 (12.4) 50.6 (9.3) <0.001
Aspartate aminotransferase (U/L) 19 (16-22) 22 (19-28) <0.001
Alanine aminotransferase (U/L) 16 (13-21) 26 (20-39) <0.001
Calcium (mEq/L) 9.22 (0.37) 9.32 (0.40) 0.001
Potassium (mEq/L) 4.02 (0.35) 4.03 (0.36) 0.913
QTc (ms) 429.0 (21.2) 439.8 (22.1) <0.001
Leukocyte count (cells/μL) 5686 (1452) 6503 (1675) <0.001
Current smoking (%) 6.9 1.9 0.014
Regular exercise (%)a 35.8 30.4 0.206
Hypertension (%)b 14.4 38.7 <0.001
Type 2 diabetes (%)c 1.0 7.3 <0.001
Metabolic syndrome (%)d 8.0 44.1 <0.001
Data are expressed as the mean (SD), median (interquartile range) or 
percentage. P values were calculated using independent two-sample test, 
Wilcoxon-Rank sum test, or chi-square test. a Regular exercise ≥ three times 
/week. b Hypertension was defined as a systolic blood pressure ≥140 mmHg, 
diastolic blood pressure ≥90 mmHg, or a current use of hypertension 
medication. c Type 2 diabetes was defined as a fasting plasma glucose ≥126 mg/
dL or a current use of diabetes medication. dMetabolic syndrome was defined 
by the presence of three or more of the following risk factors: obesity with 
BMI ≥25.0 kg/m2, high triglycerides ≥150 mg/dL, low HDL cholesterol <50 
mg/dL, elevated systolic blood pressure ≥130 mmHg, elevated diastolic blood 
pressure ≥85 mmHg, or a current use of hypertension medication, and high 
fasting plasma glucose ≥100 mg/dL or a current use of diabetes medication.
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syndrome were higher, whereas the smoking rate was lower in 
individuals with NAFLD than in individuals without.
The Pearson correlation results are listed in Table II. The 
QTc interval positively correlated with age and BMI as well 
as blood pressure, fasting plasma glucose, and triglycerides 
levels and negatively correlated with potassium and HDL 
cholesterol levels. 
coefficient (95% CI) of the QTc increment in patients with 
NAFLD was 6.4 ms (1.2–11.8) according to multiple linear 
regression analysis after adjusting for age, BMI, smoking 
status, and regular exercise as well as mean arterial pressure, 
fasting plasma glucose, triglycerides, HDL cholesterol, 
aspartate aminotransferase, alanine aminotransferase, calcium, 
potassium levels and menopause status. Similarly, the OR (95% 
CI) of NAFLD for the prolonged QTc was 2.05 (1.13–3.71) 
based on multiple logistic regression analysis after adjusting for 
the same covariables, in total women aged 20 to 74 years old. 
When stratified by menopause, the standardized β coefficient 
(95% CI) of the QTc increment in NAFLD group and the OR 
(95% CI) of NAFLD for the prolonged QTc was 7.7 ms (0.9-
15.4) and 2.87 (1.15-7.12) after adjusting for age, BMI, smoking 
status, and regular exercise as well as mean arterial pressure, 
fasting plasma glucose, triglycerides, HDL cholesterol, 
aspartate aminotransferase, alanine aminotransferase, calcium, 
and potassium levels. However, this positive association 
between NAFLD and QTc prolongation was not found in 
premenopausal women. 
DISCUSSION
In this cross-sectional study, we found a positive association 
between NAFLD and QTc prolongation in apparently healthy 
women after adjusting for potential confounding variables. Our 
findings are consistent with previous studies on the association 
between NAFLD and arrhythmogenic potentials [11-14]. 
In another case-control retrospective study of 700 admitted 
patients in the United States, Magni et al. [13] reported a 
positive association of NAFLD with conduction defects and 
Table II. Correlation between QTc interval and clinical variables.
r   p
Age (year) 0.108 0.002
Body mass index (kg/m2) 0.159 <0.001
Systolic blood pressure (mmHg) 0.238 <0.001
Diastolic blood pressure (mmHg) 0.196 <0.001
Mean arterial pressure (mmHg) 0.221 <0.001
Fasting plasma glucose (mg/dL) 0.121 <0.001
Triglyceridesa (mg/dL) 0.199 <0.001
HDL-cholesterol (mg/dL) -0.034 0.354
Aspartate aminotransferase (U/L)a 0.106 <0.001
Alanine aminotransferase (U/L)a 0.134 <0.001
Calcium, mEq/L -0.007 0.856
Potassium, mEq/L -0.157 0.012
p-values were calculated using Pearson’s correlation analysis for continuous 
variables and Spearman-rank correlation analysis for current smoking and 
regular exercise. a Indicates log-transformed values. 
Table III shows the results of multiple linear and logistic 
regression analysis to assess independent relationships 
between the NAFLD and QTc interval. The standardized β 
Table III. Results of multiple regression analysis to assess the independent relationships of NAFLD with 
QTc and prolonged QTc interval (>450 ms).
Multiple linear regression analysis Multiple logistic regression analysis
QTc (ms) Prolonged QTc (≥450 ms)
Total β 95% CI   p Odds ratio 95% CI   p
Unadjusted 10.8 7.3-14.4 <0.001 2.80 1.92-4.08 <0.001
Model 1 8.5 4.4-12.5 <0.001 2.58 1.67-3.99 <0.001
Model 2 7.2 2.8-11.5 0.001 2.39 1.47-3.87 <0.001
Model 3 6.4 1.2-11.8 0.017 2.05 1.13-3.71 0.016
Premenopausal women β 95% CI   p Odds ratio 95% CI   p 
Unadjusted 10.9 4.5-17.3 <0.001 2.20 1.23-4.01 0.008
Model 1 7.5 0.4-14.7 0.039 1.85 0.95-3.60 0.071
Model 2 8.3 0.8-15.8 0.291 1.85 0.86-3.98 0.118
Model 4 5.8 -2.1-13.8 0.149 1.47 0.62-3.50 0.381
Postmenopausal women β 95% CI    p Odds ratio 95% CI   p
Unadjusted 10.2 3.9-16.4 0.001 2.96 1.54-5.69 0.001
Model 1 9.1 2.1-16.1 0.011 3.46 1.62-7.41 0.001
Model 2 8.6 1.3-15.8 0.021 3.47 1.53-7.88 0.003
Model 4 7.7 0.9-15.4 0.038 2.87 1.15-7.12 0.023
Model 1: adjusted for age and body mass index. Model 2: adjusted for age, body mass index, smoking status, 
and regular exercise. Model 3: adjusting for age, body mass index, smoking status, regular exercise, mean 
arterial pressure, fasting plasma glucose, triglycerides, HDL-cholesterol, aspartate aminotransferase, alanine 
aminotransferase, calcium potassium levels and menopausal status. Model 4: adjusting for age, body mass 
index, smoking status, regular exercise, mean arterial pressure, fasting plasma glucose, triglycerides, HDL-
cholesterol, aspartate aminotransferase, alanine aminotransferase, calcium and potassium levels.
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identified NAFLD as a risk factor of conduction defects in 
multivariate logistic regression with a backward elimination 
method (adjusted OR: 2.38, 95% CI: 1.51–3.73). Furthermore, 
Targher et al. [11] reported that patients with NAFLD had 
a significantly higher prevalence of premature ventricular 
conduction and no sustained ventricular tachycardia as 
compared with those without NAFLD among patients with type 
2 diabetes. They also reported a positive association between 
NAFLD and QTc prolongation (adjusted OR: 2.26, 95% CI: 
1.4–3.7) in 400 Italian outpatients with type 2 diabetes [11]. 
However, the previous study populations included patients 
with type 2 diabetes with a high prevalence of NAFLD of 
around 72%. Also, the previous studies reported prolonged 
QTc intervals in subjects with NAFLD in Western populations, 
and little is known about East Asian populations in this regard. 
Recently, Hung et al. [12] found that the adjusted ORs (95% 
CIs) of the prolongation of QTc were 1.31 (1.16–2.24) in 
women and 1.87 (1.16–2.24) in apparently healthy Taiwan 
individuals. Our study confirmed that the positive associations 
between NAFLD and prolonged QTc interval can be applied 
to apparently healthy Korean women.
Several mechanisms could explain the significant 
relationship between the NAFLD components and prolonged 
QTc intervals. Nonalcoholic fatty liver disease is now regarded 
as a hepatic manifestation of obesity and the metabolic 
syndrome [15]. Obese individuals are prone to cardiac 
autonomic dysfunction such as sympathetic hyperactivity 
and augmenting myocardial refractoriness, which leads to 
arrhythmogenic potential [16, 17]. Also, insulin resistance, 
the core feature of metabolic syndrome, may lead to 
decreased potassium, affecting the prolongation of ventricular 
repolarization [18, 19]. Moreover, NAFLD is induced by 
a low-grade inflammation, which increased the visceral 
adipose tissue to promote proinflammatory mediators [15]. 
Subclinical inflammation mediated by inflammatory cytokines 
may affect myocardium by modulating specific ion channels. 
These processes result in the prolongation of action potential 
duration, which in turn increases QTc duration [20]. 
Our study had several limitations. First, it was of a cross-
sectional design, suggesting that caution should be used 
in causal and temporal interpretations; thus, it cannot be 
concluded whether NAFLD is a risk factor actively involved 
in the development of QTc prolongation. Further large 
prospective studies are warranted to explain these possible 
associations between NAFLD and QTc prolongation. Second, 
because the study participants were volunteers undergoing 
health promotion screenings in a single hospital and appeared 
to be slightly healthier individuals than most community-based 
cohorts, the study population may not be representative of 
the general population. Third, we did not consider the effects 
of medicines such as anti-arrhythmics or anti-depressants 
in relation to cardiac rhythm. Because, this study used the 
secondary dataset from a health promotion center, these 
variables were not fully adjusted in the statistical models.
CONCLUSION
We confirmed the arrhythmogenic potential of NAFLD 
in apparently healthy Korean women, particularly in 
postmenopausal women. Our findings suggest that careful 
monitoring of ECGs is necessary to evaluate possible 
arrhythmic risk in individuals with NAFLD.
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